Loading...
Biomx Inc (PHGE) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. The lack of positive financial performance, absence of significant trading trends, and no recent news catalysts make this stock less appealing. Additionally, the pre-market price decline and no proprietary trading signals further reduce its attractiveness.
The MACD is positive and expanding, indicating a potential upward trend, but the RSI is neutral at 61.647, suggesting no strong momentum. Moving averages are converging, and the stock is trading near a resistance level (R1: 6.87). However, the pre-market price is down 3.12%, which could indicate short-term weakness.
Analyst Joseph Pantginis from H.C. Wainwright recently raised the price target to $26 from $15, maintaining a Buy rating. This suggests optimism about the company's future potential.
The pre-market price is also down 3.12%, indicating weak sentiment.
In Q3 2025, the company reported no revenue growth (0% YoY), a significant drop in net income (-195.06% YoY), and a sharp decline in EPS (-149.64% YoY). Gross margin remained at 0%. Overall, financial performance is poor.
H.C. Wainwright analyst Joseph Pantginis raised the price target to $26 from $15, maintaining a Buy rating. However, this optimism is not supported by strong financial performance or other positive catalysts.